Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 17.96M | $174.0M | 55.96% | +8.10M | 2026-06-30 |
| VIKING GLOBAL INVESTORS LP | 2.60M | $25.0M | 8.12% | -- | 2026-06-30 |
| Blackstone Inc. | 2.40M | $23.0M | 7.49% | -- | 2026-06-30 |
| 5AM Venture Management, LLC | 2.35M | $22.0M | 7.33% | -- | 2026-06-30 |
| Venrock Adviser, LLC | 2.04M | $19.0M | 6.37% | +434.0K | 2026-06-30 |
| FRANKLIN RESOURCES INC | 2.00M | $19.0M | 6.22% | +1.48M | 2026-06-30 |
| Caligan Partners LP | 1.74M | $16.0M | 5.41% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 981.8K | $9.0M | 3.06% | +774.1K | 2026-06-30 |
| SAMSARA BIOCAPITAL, LLC | 954.9K | $9.0M | 2.98% | +663.2K | 2026-06-30 |
| Blue Owl Capital Holdings LP | 874.5K | $8.0M | 2.73% | -- | 2026-06-30 |
